PARP Drugs Help Some Breast Cancer Patients, But They’re No Magic Bullet
For patients with metastatic breast cancer, doctors don’t yet know how to predict long-term responses to this PARP drug.
writer, health care advocate, physician
For patients with metastatic breast cancer, doctors don’t yet know how to predict long-term responses to this PARP drug.
The paradigm for using chemo first to treat advanced breast cancer may change, as we gain experience with these new drugs.
Before choosing any treatment after genetic testing, hit the pause button. Ask questions. Get a second opinion.
A new type of cancer medication, called PARP inhibitors, is gaining traction in clinical practice.
Lynparza—a PARP inhibitor taken as an oral tablet, daily— keeps qualified cases of advanced ovarian cancer in check for two years, as compared to placebo.
Anne Parker’s perspective on cancer care – as a family member, patient and advocate – spans over 50 years.
By telling her story, she helps break the mystery and stigma that deter honest and needed discussion about cancer-causing, inherited genetic mutations.
What this movie gets right is the loneliness of having cancer – the feeling that kicks in when you’re awake and alive in some sort of hyper-sterile place receiving therapy, where there’s no one else.
What’s great about this piece, and what’s wrong about it, is that it comes from an individual woman.